95 related articles for article (PubMed ID: 3012133)
1. Leads from the MMWR. Classification system for human T-lymphotropic virus type III/lymphadenopathy-associated virus infections.
JAMA; 1986 Jul; 256(1):20-1, 24-5. PubMed ID: 3012133
[No Abstract] [Full Text] [Related]
2. Classification system for human T-lymphotropic virus type III/lymphadenopathy-associated virus infections. Centers for Disease Control, U.S. Department of Health and Human Services.
Ann Intern Med; 1986 Aug; 105(2):234-7. PubMed ID: 3014942
[TBL] [Abstract][Full Text] [Related]
3. Classification system for human T-lymphotropic virus type III/lymphadenopathy-associated virus infections.
Centers for Disease Control (CDC)
MMWR Morb Mortal Wkly Rep; 1986 May; 35(20):334-9. PubMed ID: 3010072
[TBL] [Abstract][Full Text] [Related]
4. A classification of HTLV-III infection based on 75 cases seen in a suburban community.
Kaplan MH; Pahwa SG; Popovic M; Sarngadharan MG; Gallo RC
Cancer Res; 1985 Sep; 45(9 Suppl):4655s-4658s. PubMed ID: 2990703
[TBL] [Abstract][Full Text] [Related]
5. Classification of HTLV-III/LAV-related diseases.
Haverkos HW; Gotlieb MS; Killen JY; Edelman R
J Infect Dis; 1985 Nov; 152(5):1095. PubMed ID: 2995508
[No Abstract] [Full Text] [Related]
6. Leads from the MMWR. Experimental infection of chimpanzees with lymphadenopathy-associated virus.
JAMA; 1984 Aug 24-31; 252(8):995. PubMed ID: 6086967
[No Abstract] [Full Text] [Related]
7. Revision of the case definition of acquired immunodeficiency syndrome for national reporting--United States. Centers for Disease Control, Department of Health and Human Services.
Ann Intern Med; 1985 Sep; 103(3):402-3. PubMed ID: 2992336
[TBL] [Abstract][Full Text] [Related]
8. Acute myelofibrosis and infection with the lymphadenopathy-associated virus/human T-lymphotropic virus type III.
Darne C; Solal-Celigny P; Herrera A; Ramond MJ; Brun-Vezinet F; Brousse N; Boivin P
Ann Intern Med; 1986 Jan; 104(1):130-1. PubMed ID: 3000243
[No Abstract] [Full Text] [Related]
9. [Prevalence of antibodies against the lymphadenopathy-associated virus/human T-cell lymphotropic virus type III (LAV/HTLV) in a population of homosexuals in Mexico].
Sierra Madero JG; Ponce de León S; Ruiz Palacios G; Tinoco JC; Calva JJ; Zamora EE
Salud Publica Mex; 1986; 28(2):180-5. PubMed ID: 3014666
[No Abstract] [Full Text] [Related]
10. Update: evaluation of human T-lymphotropic virus. Type III/lymphadenopathy-associated virus infection in health-care personnel--United States. Centers for Disease Control.
Conn Med; 1985 Nov; 49(11):772. PubMed ID: 2998701
[No Abstract] [Full Text] [Related]
11. Clinical spectrum of HTLV-III in humans.
Groopman JE
Cancer Res; 1985 Sep; 45(9 Suppl):4649s-4651s. PubMed ID: 2990701
[TBL] [Abstract][Full Text] [Related]
12. Immunization of children infected with human T-lymphotropic virus type III/ lymphadenopathy-associated virus.
Centers for Disease Control (CDC)
MMWR Morb Mortal Wkly Rep; 1986 Sep; 35(38):595-8,603-6. PubMed ID: 3018471
[No Abstract] [Full Text] [Related]
13. Primary lymph node pathology in AIDS and AIDS-related lymphadenopathy.
Ewing EP; Chandler FW; Spira TJ; Brynes RK; Chan WC
Arch Pathol Lab Med; 1985 Nov; 109(11):977-81. PubMed ID: 2996462
[TBL] [Abstract][Full Text] [Related]
14. Lymphadenopathy syndrome in two thalassemic patients after LAV contamination by blood transfusion.
Boiteux F; Vilmer E; Girot R; Muller JY; Rouzioux C; Chamaret S; Montagnier L
N Engl J Med; 1985 Mar; 312(10):648-9. PubMed ID: 2983204
[No Abstract] [Full Text] [Related]
15. Leads from the MMWR. Recommendations for providing dialysis treatment to patients infected with human T-lymphotropic virus.
JAMA; 1986 Aug; 256(6):703-4. PubMed ID: 3014176
[No Abstract] [Full Text] [Related]
16. Recommendations for providing dialysis treatment to patients infected with human T-lymphotropic virus type III/lymphadenopathy-associated virus.
Centers for Disease Control (CDC)
MMWR Morb Mortal Wkly Rep; 1986 Jun; 35(23):376-8, 383. PubMed ID: 3012309
[No Abstract] [Full Text] [Related]
17. Human T-cell lymphotropic virus type III associated disorders. The spectrum in the heterosexual population.
Gill PS; Levine AM; Meyer PR; Aguilar SL; Rarick M; Parker JW; Rasheed S
Arch Intern Med; 1986 Aug; 146(8):1501-4. PubMed ID: 3015064
[TBL] [Abstract][Full Text] [Related]
18. Prospective study of cytotoxic T lymphocyte responses to influenza and antibodies to human T lymphotropic virus-III in homosexual men. Selective loss of an influenza-specific, human leukocyte antigen-restricted cytotoxic T lymphocyte response in human T lymphotropic virus-III positive individuals with symptoms of acquired immunodeficiency syndrome and in a patient with acquired immunodeficiency syndrome.
Shearer GM; Salahuddin SZ; Markham PD; Joseph LJ; Payne SM; Kriebel P; Bernstein DC; Biddison WE; Sarngadharan MG; Gallo RC
J Clin Invest; 1985 Oct; 76(4):1699-704. PubMed ID: 2997287
[TBL] [Abstract][Full Text] [Related]
19. Herpes zoster and the classification of HTLV-III/LAV-related diseases.
Deresinski SC
J Infect Dis; 1986 Jul; 154(1):190. PubMed ID: 3011924
[No Abstract] [Full Text] [Related]
20. Spectrum of human T-cell lymphotropic virus type III infection in children. Recognition of symptomatic, asymptomatic, and seronegative patients.
Pahwa S; Kaplan M; Fikrig S; Pahwa R; Sarngadharan MG; Popovic M; Gallo RC
JAMA; 1986 May; 255(17):2299-305. PubMed ID: 3007791
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
